In contrast, therapy development based on a stem cell theory of cancer focuses on an integrated approach in which one treats both CSCs (and non-CSCs) with their unique (or lack of) stem-ness properties, including cancer metabolomics, along with their obligate onco-niches (such as by modulating or reducing NFkB signaling) [65]. Here, NFKB1 is linked to cancer.